162 related articles for article (PubMed ID: 24054322)
21. Mixed lineage kinase domain-like protein induces RGC-5 necroptosis following elevated hydrostatic pressure.
Liao L; Shang L; Li N; Wang S; Wang M; Huang Y; Chen D; Huang J; Xiong K
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):879-889. PubMed ID: 28981598
[TBL] [Abstract][Full Text] [Related]
22. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.
Chen W; Zhou Z; Li L; Zhong CQ; Zheng X; Wu X; Zhang Y; Ma H; Huang D; Li W; Xia Z; Han J
J Biol Chem; 2013 Jun; 288(23):16247-16261. PubMed ID: 23612963
[TBL] [Abstract][Full Text] [Related]
23. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.
Zhao J; Jitkaew S; Cai Z; Choksi S; Li Q; Luo J; Liu ZG
Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5322-7. PubMed ID: 22421439
[TBL] [Abstract][Full Text] [Related]
24. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
25. RIP kinase 3 in necroptosis: does it take two or more to kill?
Kim C; Pasparakis M
Cell Death Differ; 2014 Oct; 21(10):1505-7. PubMed ID: 25196971
[No Abstract] [Full Text] [Related]
26. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis.
Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR
Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392
[TBL] [Abstract][Full Text] [Related]
27. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
Hu S; Chang X; Zhu H; Wang D; Chen G
Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
[TBL] [Abstract][Full Text] [Related]
28. Necroptosis: a crucial pathogenic mediator of human disease.
Choi ME; Price DR; Ryter SW; Choi AMK
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333
[TBL] [Abstract][Full Text] [Related]
29. Evolutionary divergence of the necroptosis effector MLKL.
Tanzer MC; Matti I; Hildebrand JM; Young SN; Wardak A; Tripaydonis A; Petrie EJ; Mildenhall AL; Vaux DL; Vince JE; Czabotar PE; Silke J; Murphy JM
Cell Death Differ; 2016 Jul; 23(7):1185-97. PubMed ID: 26868910
[TBL] [Abstract][Full Text] [Related]
30. Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.
Garnish SE; Meng Y; Koide A; Sandow JJ; Denbaum E; Jacobsen AV; Yeung W; Samson AL; Horne CR; Fitzgibbon C; Young SN; Smith PPC; Webb AI; Petrie EJ; Hildebrand JM; Kannan N; Czabotar PE; Koide S; Murphy JM
Nat Commun; 2021 Apr; 12(1):2211. PubMed ID: 33850121
[TBL] [Abstract][Full Text] [Related]
31. Interferon-γ induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity.
Chen J; Kuroki S; Someda M; Yonehara S
J Biol Chem; 2019 Aug; 294(32):11994-12006. PubMed ID: 31217278
[TBL] [Abstract][Full Text] [Related]
32. Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it.
Yoon S; Bogdanov K; Kovalenko A; Wallach D
Cell Death Differ; 2016 Feb; 23(2):253-60. PubMed ID: 26184911
[TBL] [Abstract][Full Text] [Related]
33. ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.
Ma B; Marcotte D; Paramasivam M; Michelsen K; Wang T; Bertolotti-Ciarlet A; Jones JH; Moree B; Butko M; Salafsky J; Sun X; McKee T; Silvian LF
PLoS One; 2016; 11(11):e0165983. PubMed ID: 27832137
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.
Kaiser WJ; Sridharan H; Huang C; Mandal P; Upton JW; Gough PJ; Sehon CA; Marquis RW; Bertin J; Mocarski ES
J Biol Chem; 2013 Oct; 288(43):31268-79. PubMed ID: 24019532
[TBL] [Abstract][Full Text] [Related]
35. Neonatal obstructive nephropathy induces necroptosis and necroinflammation.
Popper B; Rammer MT; Gasparitsch M; Singer T; Keller U; Döring Y; Lange-Sperandio B
Sci Rep; 2019 Dec; 9(1):18600. PubMed ID: 31819111
[TBL] [Abstract][Full Text] [Related]
36. Complex roles of necroptosis in cancer.
Zhu F; Zhang W; Yang T; He SD
J Zhejiang Univ Sci B; 2019 May; 20(5):399-413. PubMed ID: 31090266
[TBL] [Abstract][Full Text] [Related]
37. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of Human Necrosome Interactions in
Ji Y; Ward LA; Hawkins CJ
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33503908
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
[TBL] [Abstract][Full Text] [Related]
40. Structural insights into RIP3-mediated necroptotic signaling.
Xie T; Peng W; Yan C; Wu J; Gong X; Shi Y
Cell Rep; 2013 Oct; 5(1):70-8. PubMed ID: 24095729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
